Distal and local mucosal immunization with a BoHV-4-based vector delivering CpHV-1 gD confers protection against intravaginal CpHV-1 challenge in goats - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Mucosal Immunization via a BoHV-4 Vector Expressing CpHV-1 gD Provides Protection Against Intravaginal CpHV-1 Infection in Goats

  • By

  • Amienwanlen Eugene Odigie

  • Sergio Minesso

  • Valentina Franceschi

  • Grazia Greco

  • Vittorio Madia

  • Michele Camero

  • Maria Tempesta

  • Gaetano Donofrio

  • July 14, 2026

Share

  • 1

    Mucosal vaccination using a BoHV-4 vector expressing CpHV-1 gD protects goats from intravaginal CpHV-1 infection.

  • 2

    Both intravaginal and intranasal immunization routes provided complete protection against CpHV-1 disease in vaccinated goats.

  • 3

    Vaccinated goats exhibited no fever or genital pathology post-challenge, contrasting with unvaccinated controls.

  • 4

    Intravaginal immunization resulted in superior control of genital virus excretion compared to intranasal vaccination.

  • 5

    The study establishes the goat-CpHV-1 model as a valuable system for preclinical evaluation of mucosal herpesvirus vaccines.

Original Source(s)

Distal and local mucosal immunization with a BoHV-4-based vector delivering CpHV-1 gD confers protection against intravaginal CpHV-1 challenge in goats

  • by Amienwanlen Eugene Odigie, Sergio Minesso, Valentina Franceschi, Grazia Greco, Vittorio Madia, Michele Camero, Maria Tempesta, Gaetano Donofrio

  • July 14, 2026

Related Content

Counterfactual evaluation of COVID-19 control policies in South Korea: A scenario-based modeling study

Effectiveness of varicella vaccine during a varicella outbreak in a Chinese senior high school: a retrospective cohort study

Immunization Awareness Month: How RTs Help Protect Patients